ES3015621T3 - Beta-amino acid derivative, kinase inhibitor and pharmaceutical composition containing the same, and use of the same - Google Patents
Beta-amino acid derivative, kinase inhibitor and pharmaceutical composition containing the same, and use of the same Download PDFInfo
- Publication number
- ES3015621T3 ES3015621T3 ES20213242T ES20213242T ES3015621T3 ES 3015621 T3 ES3015621 T3 ES 3015621T3 ES 20213242 T ES20213242 T ES 20213242T ES 20213242 T ES20213242 T ES 20213242T ES 3015621 T3 ES3015621 T3 ES 3015621T3
- Authority
- ES
- Spain
- Prior art keywords
- compound
- intraocular pressure
- kinase
- mixture
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962955683P | 2019-12-31 | 2019-12-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES3015621T3 true ES3015621T3 (en) | 2025-05-06 |
Family
ID=74556625
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES20213242T Active ES3015621T3 (en) | 2019-12-31 | 2020-12-10 | Beta-amino acid derivative, kinase inhibitor and pharmaceutical composition containing the same, and use of the same |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11608319B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP3845276B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP7531379B2 (cg-RX-API-DMAC10.html) |
| CN (1) | CN113121443B (cg-RX-API-DMAC10.html) |
| ES (1) | ES3015621T3 (cg-RX-API-DMAC10.html) |
| TW (1) | TWI777325B (cg-RX-API-DMAC10.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230038697A (ko) * | 2020-07-14 | 2023-03-21 | 우한 엘엘 사이언스 앤드 테크놀로지 디벨롭먼트 컴퍼니, 리미티드 | Rock 억제제 및 이의 제조 방법과 용도 |
| WO2025143152A1 (ja) | 2023-12-27 | 2025-07-03 | 全薬工業株式会社 | チアゾリル－ピラゾロ［１，５－ａ］ピリジン化合物、およびそのＭＹＬＫ４阻害剤としての使用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200306819A (en) * | 2002-01-25 | 2003-12-01 | Vertex Pharma | Indazole compounds useful as protein kinase inhibitors |
| CN101253152A (zh) * | 2005-09-02 | 2008-08-27 | 安斯泰来制药株式会社 | 作为rock抑制剂的酰胺衍生物 |
| US8504218B2 (en) | 2007-07-31 | 2013-08-06 | General Electric Company | Methods and systems for universal input output for vehicle control |
| JP2011507850A (ja) * | 2007-12-21 | 2011-03-10 | ザ スクリプス リサーチ インスティチュート | Ｒｈｏキナーゼインヒビターとしてのアニリドおよびアナログ |
| WO2010036316A1 (en) | 2008-09-24 | 2010-04-01 | Yangbo Feng | Urea and carbamate compounds and analogs as kinase inhibitors |
| WO2010126626A2 (en) * | 2009-05-01 | 2010-11-04 | Aerie Pharmaceuticals, Inc. | Dual mechanism inhibitors for the treatment of disease |
| KR101768235B1 (ko) | 2009-07-28 | 2017-08-14 | 오노 야꾸힝 고교 가부시키가이샤 | 이환식 화합물 및 이의 의약 용도 |
| KR102074020B1 (ko) | 2012-07-13 | 2020-02-05 | 산텐 세이야꾸 가부시키가이샤 | 술폰아미드 화합물의 조합 |
| EP2961746B1 (en) * | 2013-02-28 | 2018-01-03 | Bristol-Myers Squibb Company | Phenylpyrazole derivatives as potent rock1 and rock2 inhibitors |
| AU2016264220A1 (en) | 2015-05-18 | 2018-01-04 | Translational Drug Development Llc | Heterocyclic compounds as kinase inhibitors |
| JP2019529359A (ja) * | 2016-08-19 | 2019-10-17 | アエリエ ファーマシューティカルズ インコーポレイテッド | ベータ−アミノ−イソキノリニルアミド化合物 |
| WO2018094362A1 (en) * | 2016-11-21 | 2018-05-24 | Translational Drug Development, Llc | Heterocyclic compounds as kinase inhibitors |
| CN111050766A (zh) * | 2017-07-21 | 2020-04-21 | 卡德门企业有限公司 | Rho相关含卷曲螺旋蛋白激酶的抑制剂 |
| US20210087184A1 (en) * | 2018-03-14 | 2021-03-25 | Aerie Pharmaceuticals, Inc. | Amino-benzoisothiazole and amino-benzoisothiadiazole amide compounds |
-
2020
- 2020-12-10 CN CN202011454931.0A patent/CN113121443B/zh active Active
- 2020-12-10 JP JP2020204848A patent/JP7531379B2/ja active Active
- 2020-12-10 TW TW109143679A patent/TWI777325B/zh active
- 2020-12-10 EP EP20213242.9A patent/EP3845276B1/en active Active
- 2020-12-10 US US17/117,615 patent/US11608319B2/en active Active
- 2020-12-10 ES ES20213242T patent/ES3015621T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| TW202126628A (zh) | 2021-07-16 |
| JP7531379B2 (ja) | 2024-08-09 |
| EP3845276B1 (en) | 2025-01-29 |
| CN113121443A (zh) | 2021-07-16 |
| TWI777325B (zh) | 2022-09-11 |
| US11608319B2 (en) | 2023-03-21 |
| CN113121443B (zh) | 2024-07-09 |
| EP3845276A1 (en) | 2021-07-07 |
| US20220363645A1 (en) | 2022-11-17 |
| JP2021113185A (ja) | 2021-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2393768T3 (es) | Derivado de quinolina para el tratamiento de enfermedades retinianas | |
| ES2289349T3 (es) | Derivados de heteroaril-pirimidina como inhibidores de jak. | |
| EP2590655B1 (en) | Compounds and methods for inhibiting phosphate transport | |
| ES2594378T3 (es) | Derivados de la bencilidenoguanidina y uso terapéutico para el tratamiento de enfermedades por mal plegamiento proteico | |
| EP2590965B1 (en) | Compounds and methods for inhibiting phosphate transport | |
| ES2865173T3 (es) | Inhibición del canal iónico receptor del potencial transitorio A1 | |
| ES2709034T3 (es) | Pirimido[4,5-b]quinolina-4,5 (3h,10h)-dionas como supresores de mutaciones sin sentido | |
| ES3016961T3 (en) | Amino- or ammonium-containing sulfonic acid derivatives and their medical use | |
| ES2691805T3 (es) | Medicamento para el tratamiento de una enfermedad ocular | |
| WO2012072033A1 (zh) | 取代的2，3-二氮杂萘酮化合物及其用途 | |
| ES2874882T3 (es) | Derivados de carboxamida | |
| JP2015504919A (ja) | プロテアソーム活性を調節する化合物 | |
| JP2015513317A (ja) | プロテアソーム活性を増強する化合物 | |
| CN103130737A (zh) | 环己烷胺类化合物及其作为抗精神分裂症药物的应用 | |
| KR20210041596A (ko) | 산화질소 방출 포스포디에스테라제 타입 5 억제제 | |
| ES2357863T3 (es) | Derivados de la sulfonamida. | |
| JP7138768B2 (ja) | ジメチルホスフィンオキシド化合物 | |
| ES2760373T3 (es) | Compuestos y procedimientos para prevenir o tratar la muerte de células ciliadas sensoriales | |
| EP3845276B1 (en) | Beta-amino acid derivative, kinase inhibitor and pharmaceutical composition containing the same, and use of the same | |
| ES2832333T3 (es) | Profármacos de creatina, composiciones y métodos de uso de los mismos | |
| WO2021227895A1 (zh) | 一种一氧化氮供体型ripasudil衍生物及其制备方法和用途 | |
| KR102758256B1 (ko) | β-아미노산 유도체, 키나아제 억제제 및 이를 함유하는 약학 조성물 | |
| ES2937789T3 (es) | Activadores de AMPK directos de benzimidazol | |
| ES2929292T3 (es) | Derivados de morfolina como inhibidores de Vps34 | |
| ES2911284T3 (es) | Derivados de indolizina, composición y métodos de uso |